Metrics to compare | FDC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFDCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.3x | 30.9x | −0.2x | |
PEG Ratio | 0.52 | 0.83 | 0.00 | |
Price/Book | 2.4x | 4.4x | 2.6x | |
Price / LTM Sales | 2.8x | 4.1x | 2.8x | |
Upside (Analyst Target) | - | 13.7% | 65.6% | |
Fair Value Upside | Unlock | −1.5% | 10.0% | Unlock |
FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastroenterology, ophthalmology, anti-diabetics, cardiovascular care, respiratory care, gynaecology, dermatology, paediatrics, analgesics, vitamins, and nutritional health in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured oral rehydration solution powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zifi-0, Zocon, Mycoderm, Zathrin, Victofol, Cotaryl, Ziglim-M, Amodep-AT, MumMum 1, Victofol Injection, Simyl MCT, Victofol – C, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.